Daclizumab - da-KLIZ-yoo-mab belongs to a group of medication known as immunosuppressive agents. It is using to lower the body's natural immunity in diseaseds who receive kidney transplants.
When a patient receives a kidney transplant, the body's white blood cells will try to get rid of - reject the transplanted kidney. Daclizumab works by preventing the white blood cells from getting rid of the transplanted kidney. The effect of daclizumab on the white blood cells may also reduce the body's ability to fight infections.
Daclizumab is to be aplaying only by or under the immediate supervision of your family doctor. It is available in the following dosage form:
Some commonly using brand names are:
In the USA
Another commonly using name is dacliximab .